Jennifer J. Rhodes, EVP and chief legal officer at Acadia Pharmaceuticals Inc. ($ACAD), made one open market sale of common shares in the last 365 days, totaling $162 thousand. Her most recent sale occurred on February 9, 2026. This ranks her 8,842nd among 11,678 insiders by sales value, well below the average of $8.6 million across roughly 6 transactions per insider. She reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 25, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | S | Common Stock | 3844 | $21.47 | 11,280.0000 | 170,650,000 | 25.42% | 0.00% |
| March 24, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | M | Common Stock | 7515 | $0.00 | 15,124.0000 | 170,650,000 | 98.76% | 0.00% |
| March 24, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | M | Restricted Stock Units | 7515 | $0.00 | 22,547.0000 | 170,650,000 | 25.00% | 0.00% |
| March 6, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | A | Stock Option (Right to Buy) | 90691 | $0.00 | 90,691.0000 | 170,650,000 | 9999.99% | 0.05% |
| March 6, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | A | Restricted Stock Units | 26382 | $0.00 | 26,382.0000 | 170,650,000 | 9999.99% | 0.02% |
| Feb. 6, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | M | Restricted Stock Units | 12944 | $0.00 | 12,945.0000 | 170,650,000 | 50.00% | 0.01% |
| Feb. 6, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | M | Common Stock | 12944 | $0.00 | 14,559.0000 | 170,650,000 | 801.49% | 0.01% |
| Feb. 9, 2026 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | S | Common Stock | 6950 | $23.38 | 7,609.0000 | 170,650,000 | 47.74% | 0.00% |
| March 24, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | A | Stock Option (Right to Buy) | 102289 | $0.00 | 102,289.0000 | 166,362,000 | 9999.99% | 0.06% |
| March 24, 2025 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | A | Restricted Stock Units | 30062 | $0.00 | 30,062.0000 | 166,362,000 | 9999.99% | 0.02% |
| Feb. 6, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | A | Restricted Stock Units | 25889 | $0.00 | 25,889.0000 | 163,819,000 | 9999.99% | 0.02% |
| Feb. 6, 2024 | ACADIA PHARMACEUTICALS INC | $ACAD | Rhodes Jennifer J | EVP, CHIEF LEGAL OFFICER, SEC | A | Stock Option (Right to Buy) | 126589 | $0.00 | 126,589.0000 | 163,819,000 | 9999.99% | 0.08% |